Delivering innovative solutions by connecting technology and business to drive sustainable growth

08 June 2021

Andreas Fischer (CIO)

As ONE Evonik, innovation is deeply rooted in group strategy Leading beyond chemistry to drive sustainable growth and profitability

Ongoing portfolio transformation

  • Target: Specialty portfolio with 100% growth businesses

Ambitious financial targets

  • EBITDA margin: 18-20%
  • Cash conversion ratio: >40%
  • ROCE: 11%

LEADING

BEYOND

CHEMISTRY

Innovation & Sustainability as growth drivers

  • €1 bn additional sales from innovation growth fields by 2025
  • Growing portfolio share of "Next Generation Solutions"

Performance-driven corporate culture

  • Further drive
    gender and cultural diversity
  • Deliver on efficiency programs in Administration & Operations

2 | 08 June 2021 | Andreas Fischer | Research & Development

The ONE Evonik strategy is reflected in our new RD&I setup

ONE Evonik

Executive Board

Divisions

Specialty

Nutrition &

Smart

Performance

Technology &

Additives

Care

Materials

Materials

Infrastructure

Regions

Research, Development &

Innovation

ONE RD&I

Research, Development &

Innovation

R&D Nutrition & Care

R&D Resource Efficiency

R&D Performance Materials

Creavis

Evonik Venture Capital

Steering

ONE Portfolio

  • Leverage Synergies ("Speed of Light" - mRNA)
  • Integrate sustainability in portfolio management by PARC analysis

3 | 08 June 2021 | Andreas Fischer | Research & Development

Our strategy

with an aligned set of goals contributing to Evonik's success

We deliver innovative solutions by connecting technology & business to drive sustainable growth

Sustainability

Growth & Profitability

Platform Technologies

We develop sustainable solutions

We create opportunities

We make the best use

as a key factor in decision-making and key

to achieve our financial target of €1 bn

of our resources with shared technology

success factor for future growth

additional sales by 2025 with products of

platforms and focus on our most promising

our six innovation growth fields

projects

  • Deliver R&D on new product and processes
  • Create & grow businesses beyond core
  • Recruit and develop new talents

Our activities…

  • Steer portfolio and optimize resource allocation
  • Manage partnerships with key customers, startups and universities
  • Build reputation as a seal of quality for customers, investors, employees and talents

4 | 08 June 2021 | Andreas Fischer | Research & Development

Bundling our biotechnology competencies into one platform Consistent focus on future topics

Biotechnology Platform

Program & Project Management

Systems Biotechnology

Process Biotechnology

In silico

Target

Microbial

~200 employees

Factory

Process Design

> 100 products

Systems

Systems

Systems

Success Stories

Gut Health Solutions

Veramaris

Biosurfactants

Lab Operations

5 | 08 June 2021 | Andreas Fischer | Research & Development

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

Disclaimer

Evonik Industries AG published this content on 08 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2021 07:56:07 UTC.